Common (5-15% of users): Mild injection site reactions, minor digestive changes Uncommon (1-5%): Sleep changes, temporary fatigue, mild headache Rare (under 1%): Dizziness, flushing, mood changes Very Rare: Serious adverse effects rarely reported in community use Theoretical Concerns BPC-157s ability to stimulate angiogenesis (blood vessel formation) raises theoretical questions about its use in individuals with active cancer or high cancer risk
"Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry"
They should be approached with realistic expectations and appropriate screening
BPC-157 has been shown in research settings to influence angiogenic signaling, nitric oxide pathways, and fibroblast activity, while TB-500 has been studied for its role in actin regulation, cell migration, and wound-healing mechanisms
magna cum laude , 1990, Harvard Law School Experience Mitchell Hamline School of Law: president and dean, 2015-
Nat Rev Microbiol (2022) 20:70720